HeLa cells and iPSC‐MNs expressing mutated FUS, as well as ALS patients’ fibroblasts and spinal cord MNs are vulnerable to Hsp90 inhibition and show defective induction of DYRK3. The gene discussed is HSP90AA1; the disease is amyotrophic lateral sclerosis.